Dānija -
dāņu -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydrochlorthiazid "teva" 160+25 mg filmovertrukne tabletter
teva b.v. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160+25 mg
Dānija -
dāņu -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydrochlorthiazid "teva" 80+12,5 mg filmovertrukne tabletter
teva b.v. - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 80+12,5 mg
Dānija -
dāņu -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydroklortiazid "jubilant" 160 mg+25 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160 mg+25 mg
Dānija -
dāņu -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydrochlorothiazide "krka" 320+12,5 mg filmovertrukne tabletter
krka sverige ab - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 320+12,5 mg
Dānija -
dāņu -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydrochlorothiazide "krka" 320+25 mg filmovertrukne tabletter
krka sverige ab - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 320+25 mg
Dānija -
dāņu -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydroklortiazid "jubilant" 80 mg+12,5 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 80 mg+12,5 mg
Dānija -
dāņu -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydroklortiazid "jubilant" 320 mg+25 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 320 mg+25 mg
Eiropas Savienība -
dāņu -
EMA (European Medicines Agency)
imprida hct
novartis europharm ltd. - amlodipin, valsartan, hydrochlorthiazid - forhøjet blodtryk - angiotensin ii antagonister, plain, angiotensin ii antagonister, kombinationer - behandling af essentiel hypertension som substitution terapi hos voksne patienter, hvis blodtryk er tilstrækkeligt kontrolleret på kombinationen af amlodipin, valsartan og hydrochlorthiazid (hct), taget enten tre single-komponent formuleringer eller som en dual-komponent og en enkelt-komponent formulering.
Eiropas Savienība -
dāņu -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Eiropas Savienība -
dāņu -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.